跳至主要内容
临床试验/ITMCTR1900002759
ITMCTR1900002759招募中1 期

Study for metabolic biomarkers of asthmatic children and the therapeutic effect of Xiao-Er Xuan-Fei Ping-Chuan decoction

Affiliated Hospital of Nanjing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
1 至 12(—)
性别
All

入选标准

  • The inclusion criteria of the general observation group:
  • (1) those who meet the diagnostic criteria of Western Medicine issued by the Chinese Academy of Pediatrics for the diagnosis and prevention of children's bronchial asthma (2016 Edition);
  • (2) Aged 1 and 12 years old;
  • (3) informed consent, voluntary subjects. The process of obtaining informed consent shall be in accordance with the provisions of GCP.
  • The inclusion criteria of the treatment group:
  • (1) those who meet the diagnostic criteria of Western Medicine issued by the Chinese Academy of Pediatrics (2016 Edition), the treatment group should meet the syndrome differentiation criteria of traditional Chinese medicine;
  • (2) Aged 1 and 12 years old;
  • (3) those who have acute onset, the condition is mild or moderate according to the above scoring criteria; this asthma attack has not occurred. Use of any relevant treatment drugs;
  • (4) informed consent, voluntary subjects. The process of obtaining informed consent shall be in accordance with the provisions of GCP.

排除标准

  • The exclusion criteria of the general observation group:
  • (1) other diseases that may cause asthma or dyspnea may affect the efficacy judgment;
  • (2) patients with primary diseases such as cardiovascular, cerebrovascular, hepatorenal and hematopoietic system;
  • (3) patients with age less than 1 year and age more than 12 years;
  • (4) patients who are participating in clinical trials of other drugs.
  • The exclusion criteria of the treatment group:
  • (1) stable or in remission stage;
  • (2) severe asthma, asthma status, critical patients, and patients with pulmonary infection;
  • (3) other diseases that may cause asthma or dyspnea may affect the efficacy judgment;
  • (4) patients with primary diseases such as cardiovascular, cerebrovascular, hepatorenal and hematopoietic system;
  • (5) medication not in accordance with the regulations Or the patients who are allergic to the components of this traditional Chinese medicine;
  • (6) the patients whose age is less than 1 year old and more than 12 years old;
  • (7) the patients who are participating in the clinical trials of other drugs.

研究者

发起方
Affiliated Hospital of Nanjing University of Chinese Medicine

相似试验